HC Wainwright & Co. Initiates Coverage On Sensei Biotherapeutics With Buy Rating, Announces Price Target of $4
HC Wainwright & Co. Initiates Coverage On Sensei Biotherapeutics With Buy Rating, Announces Price Target of $4
HC Wainwright & Co.以买入评级启动对Sensei Biotherapeutics的报道，宣布目标股价为4美元
HC Wainwright & Co. analyst Edward White initiates coverage on Sensei Biotherapeutics (NASDAQ:SNSE) with a Buy rating and announces Price Target of $4.
HC Wainwright & Co. 分析师爱德华·怀特以买入评级开始对Sensei Biotherapeutics（纳斯达克股票代码：SNSE）进行报道，并宣布目标股价为4美元。
译文内容由第三方软件翻译。
以上内容仅用作资讯或教育之目的，不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。